financetom
Business
financetom
/
Business
/
Inter & Co's Q2 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Inter & Co's Q2 Earnings, Revenue Rise
Aug 7, 2024 6:51 AM

09:16 AM EDT, 08/07/2024 (MT Newswires) -- Inter & Co (INTR) reported Q2 earnings Wednesday of 0.47 Brazilian reais ($0.084) per diluted share, up from 0.12 reais a year earlier.

Analysts polled by Capital IQ expected 0.50 reais.

Revenue for the quarter ended June 30 was 1.48 billion reais, compared with 1.15 billion reais a year earlier.

Analysts surveyed by Capital IQ expected 1.46 billion reais.

Price: 6.67, Change: +0.33, Percent Change: +5.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UBS to Maintain Switzerland Loan Book at Over $411 Billion
UBS to Maintain Switzerland Loan Book at Over $411 Billion
Sep 11, 2024
08:52 AM EDT, 09/11/2024 (MT Newswires) -- UBS (UBS) is aiming to continue providing about 350 billion Swiss francs ($411.55 billion) of loans in Switzerland as its commitment to its home market is stronger than ever, an executive said at a conference Wednesday. We want to be the partner of choice for customers and to support them on all financial...
iRhythm Technologies Secures Japanese Approval for EGC Monitoring Device
iRhythm Technologies Secures Japanese Approval for EGC Monitoring Device
Sep 11, 2024
08:45 AM EDT, 09/11/2024 (MT Newswires) -- iRhythm Technologies ( IRTC ) said Wednesday that its 14-day ECG monitoring system, Zio, received regulatory approval from Japan's pharmaceutical and medical device agency. With regulatory approval, the company said it intends to work with the Japanese Ministry of Health, Labour, and Welfare to reach a reimbursement decision for the Zio ECG monitoring...
Voya Financial to Acquire OneAmerica's Retirement Plan Business
Voya Financial to Acquire OneAmerica's Retirement Plan Business
Sep 11, 2024
08:56 AM EDT, 09/11/2024 (MT Newswires) -- Voya Financial ( VOYA ) said Wednesday it has agreed to acquire OneAmerica Financial's retirement plan business for an upfront purchase price of $50 million. The transaction includes a deferred consideration of up to $160 million, payable in Q2 2026, contingent on plan persistency and transition incentives, the company said. The deal is...
Actuate Therapeutics Says Elraglusib Granted FDA Orphan Drug Designation; Shares Rise
Actuate Therapeutics Says Elraglusib Granted FDA Orphan Drug Designation; Shares Rise
Sep 11, 2024
08:55 AM EDT, 09/11/2024 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Wednesday that the US Food and Drug Administration has granted orphan drug designation to elraglusib to treat soft tissue sarcoma. The designation is intended to support companies developing medicines for rare disorders that affect fewer than 200,000 people in the US. Shares of the biopharmaceutical company were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved